BPI labs is challenging the tirzepatide patent. This is a second challenge as Empower pharmacy was already challenging the patent. BPI includes additional imformation including a previous patent application showing GLP 1 GIP as 30mg tirzepatide injection: 10 single dose vials, weekly subcutaneous injection. Designed for consistent, easy therapy. #ConsistentTherapy #EasyInjection #SingleDoseCare Frequently asked questions we get about compounded tirzepatide! 1) Do I need a prescription? yes 2) Can my regular doctor call it in? yes if they are open to using compounds 3) Henry Meds GLP 1 Review: Bundles Sold, Prices Hidden Vaccine Alliance